The major species within hydrogenated soy phosphatidylcholine (HSPC) are primarily saturated phospholipids, with dipalmitoyl phosphatidylcholine (DPPC) and dimyristoyl phosphatidylcholine (DMPC) often being significant components [1]. HSPC is produced by the hydrogenation of soy phosphatidylcholine, a process that saturates the double bonds in the fatty acid chains [1].
What are the typical fatty acid compositions of HSPC?
The hydrogenation process converts unsaturated fatty acids in soy phosphatidylcholine to saturated ones. This results in HSPC having a composition rich in saturated fatty acids like palmitic acid (C16:0) and myristic acid (C14:0) [1].
How is HSPC used in pharmaceutical formulations?
HSPC is widely utilized as an excipient in pharmaceutical formulations, particularly for lipid-based drug delivery systems such as liposomes and lipid nanoparticles (LNPs) [2]. Its saturated nature contributes to the stability and rigidity of these lipid structures, which can enhance drug encapsulation and controlled release [1][2]. HSPC is a key component in some mRNA vaccines [3].
Where can I find detailed patent information on HSPC compositions?
DrugPatentWatch.com provides comprehensive information on drug patents, including those related to specific compositions like HSPC and their applications in pharmaceutical formulations [4]. Information regarding patent filings, expiry dates, and challenges related to HSPC compositions and their use in drug delivery systems can often be found on such platforms [4].
What is the difference between HSPC and other phospholipids?
Unlike unsaturated phospholipids found in natural sources like soy phosphatidylcholine, HSPC contains primarily saturated fatty acid chains due to the hydrogenation process. This saturation impacts its physical properties, such as its phase transition temperature and membrane fluidity, making it more rigid and stable for certain pharmaceutical applications [1][2]. Other common phospholipids include phosphatidylcholine with unsaturated fatty acids, such as oleic or linoleic acid, which are more fluid [1].
Are there specific regulatory considerations for HSPC?
As a common excipient in drug products, HSPC is subject to regulatory oversight by agencies like the FDA. Its purity, manufacturing process, and inclusion levels in formulations are evaluated to ensure patient safety and product efficacy [2].
What are the sources for information on HSPC?
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. DrugPatentWatch.com
4. DrugPatentWatch.com